Skip to main content
SpringerLink
Log in

Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: Absorption from various GI segments

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Azosemide, 5, 10, 20, and 30 mg/kg, was administered both intravenously and orally to determine the pharmacokinetics and pharmacodynamics of azosemide in rats (n=7–12). The absorption of azosemide from various segments of GI tract and the reasons for the appearance of multiple peaks in plasma concentrations of azosemide after oral administration were also investigated. After intravenous (iv) dose, the pharmacokinetic parameters of azosemide such ast 1/2, MRT, VSS, CL, CLR, and CLNR were found to be dose-dependent in the dose ranges studied. The percentages of the iv dose excreted in 8-hr urine as azosemide, MI (a metabolite of azosemide), glucuronide of azosemide, and glucuronide of MI—expressed in terms of azosemide—were also dose-dependent in the dose ranges studied. The data above suggest saturable metabolism of azosemide in rats. The measurements taken after the iv administrations such as the 8 hr urine output, the total amount of sodium and chloride excreted in 8-hr urine per 100 g body weight, and diuretic, natriuretic, kaluretic, and chloruretic efficiencies were also shown to be dose-dependent. However, the total amount of potassium excreted in 8-hr urine per 100 g body weight was dose-independent. Similar dose-dependency was also observed following oral administration. Azosemide was absorbed from all regions of GI tract studied and approximately 93.5, 79.1, 86.1, and 71.5% of the doses (5, 10, 20, and 30 mg/kg, respectively) were absorbed between 1 and 24 hr after oral administration. The appearance of multiple peaks after oral administration is suspected to be due mainly to the gastric emptying pattern. The percentages of azosemide absorbed from the GI tract as unchanged azosemide for up to 24 hr after oral doses of 5, 10, 20, and 30 mg/kg were significantly different with doses (decreased with increasing doses), suggesting that the problem of azosemide precipitating in acidic gastric juices or dissolution may have at least partially influenced the absorption of azosemide after oral administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. F. Krück, W. Bablok, E. Besenfelder, G. Betzien, and B. Kaufman. Clinical and pharmacological investigations of the new saluretic azosemide.Eur. J. Clin. Pharmacol. 14:153–161 (1978).

    Article  PubMed  Google Scholar 

  2. D. C. Brater, B. Day, S. A. Anderson, and R. Seiwell. Azosemide kinetics and dynamics.Clin. Pharmacol. Ther. 34:454–458 (1983).

    Article  CAS  PubMed  Google Scholar 

  3. D. C. Brater, S. A. Anderson, and S. Strowig. Azosemide, a “loop” diuretic, and furosemide.Clin. Pharmacol. Ther. 25:435–439 (1979).

    CAS  PubMed  Google Scholar 

  4. B. Beerman and M. Grind. Clinical pharmacokinetics of some newer diuretics.Clin. Pharmacokin. 13:254–266 (1987).

    Article  Google Scholar 

  5. S. H. Lee and M. G. Lee. Stability, tissue metabolism, tissue distribution and blood partition of azosemide.Biopharm. Drug Dispos. 16:547–561 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. F. Kuzuya. Phase I study of azosemide (SK-110): single and multiple dose study.Int. J. Clin. Pharmacol. Ther. Toxicol. 21:10–23 (1983).

    CAS  PubMed  Google Scholar 

  7. S. H. Lee, W. G. Shin, M. G. Lee, and N. D. Kim. Arterial and venous blood sampling in pharmacokinetic studies: Azosemide in rabbits.Biopharm. Drug Dispos. 15:305–316 (1994).

    Article  CAS  PubMed  Google Scholar 

  8. S. H. Lee, M. G. Lee, and N. D. Kim. Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: Absorption from various GI segments.J. Pharmacokin. Biopharm. 22:1–17 (1994).

    Article  CAS  Google Scholar 

  9. S. H. Lee and M. G. Lee. Determination of azosemide and its metabolite in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography.J. Chromatogr. Biomed. Appl. 656:367–372 (1994).

    Article  CAS  Google Scholar 

  10. T. Li, M. G. Lee, and W. L. Chiou. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.J. Pharmacokin. Biopharm. 14:495–509 (1986).

    Article  CAS  Google Scholar 

  11. W. H. Yoon, S. H. Lee, and M. G. Lee. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous bumetanide.J. Pharm. Sci. 84:236–242 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. M. G. Lee and W. L. Chiou. Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism.J. Pharmacokin. Biopharm. 11:623–640 (1983).

    Article  CAS  Google Scholar 

  13. F-H. Hsu, T. Prueksaritanont, M. G. Lee, and W. L. Chiou. The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: Extrapolation to human data based on the body surface area concept.J. Pharmacokin. Biopharm. 15:369–386 (1987).

    Article  CAS  Google Scholar 

  14. M. Gibaldi and D. Perrier.Pharmacokinetics, Second Ed., Marcel Dekker, New York 1982.

    Google Scholar 

  15. W. L. Chiou. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve.J. Pharmacokin. Biopharm. 6:539–546 (1978).

    Article  CAS  Google Scholar 

  16. S. H. Kim, Y. M. Choi, and M. G. Lee. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition.J. Pharmacokin. Biopharm. 21:1–17 (1993).

    Article  CAS  Google Scholar 

  17. W. L. Chiou. New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimen.J. Pharm. Sci. 68:1068–1069 (1979).

    Google Scholar 

  18. S. H. Lee and M. G. Lee. Factors influencing the protein binding of azosemide using an equilibrium dialysis technique.Biopharm. Drug Dispos. 16:615–626 (1995).

    Article  CAS  PubMed  Google Scholar 

  19. H. A. Ha, S. H. Lee, O. N. Kim, S. H. Kim, and M. G. Lee. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.Res. Commun. Mol. Pathol. Pharmacol. 93:109–128 (1996).

    CAS  PubMed  Google Scholar 

  20. T. Asano, T. Inoue, and M. Kurono. Disposition of azosemide. I. Distribution, metabolism and excretion following intravenous administration to rats.Yakugaku Zasshi 104:1181–1190 (1984).

    CAS  PubMed  Google Scholar 

  21. T. Inoue, M. Hayashi, A. Inoue, Y. Nakayama, Y. Hori, and M. Okada. Behavior of azosemide (SK-110) in the body—A study on ADME of azosemide in rats, rabbits, dogs and monkeys.Kiso to Rinsho (The Clinical Reports)18:429–440 (1984).

    Google Scholar 

  22. L. L. Boles Ponto and R. D. Schoenwal., Furosemide (Frusemide). A pharmacokinetic/pharmacodynamic review (Parts I and II).Clin. Pharmacokin. 18:381–408; 460–471 (1990).

    Article  Google Scholar 

  23. B. Odlind, B. Beermann, and B. Lindström. Coupling between renal tubular secretion and effect of bumetanide.Clin. Pharmacol. Ther. 34:805–809 (1983).

    Article  CAS  PubMed  Google Scholar 

  24. M. G. Lee, T. Li, and W. L. Chiou. Effects of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide.Biopharm. Drug Dispos. 7:537–547 (1986).

    Article  CAS  PubMed  Google Scholar 

  25. G. Giebisch. In M. Martines-Maldonado (ed),Methods of Pharmacology, Vol. 4A, Plenum, New York, pp. 121–164, 1976.

    Chapter  Google Scholar 

  26. V. S. Chungi, I. W. Dittert, and R. B. Smith. Gastrointestinal sites of furosemide absorption in rats.Int. J. Pharm. 4:27–38 (1979).

    Article  CAS  Google Scholar 

  27. M. G. Lee, M.-L. Chen, and W. L. Chiou. Pharmacokinetics of drugs in blood II: Unusual distribution and storage effect of furosemide.Res. Commun. Chem. Pathol. Pharmacol. 34:17–23 (1981).

    CAS  PubMed  Google Scholar 

  28. H. W. Chang, E. J. Yoon, M. G. Lee, and N. D. Kim. Pharmacokinetics of drugs in blood VI: Unusual distribution and storage effect of bumetanide.Seoul Univ. J. Pharm. Sci. 13:1–17 (1988).

    Google Scholar 

  29. Y. Suzuki, M. Ito, and T. Komura. Effects on diuresis, plasma renin activity, and urinary prostaglandin E excretion in normal rats.Folia Pharmacol. Japon 79:317–325 (1982).

    Article  CAS  Google Scholar 

  30. M. Hayashi, K. Nakano, K. Asano, K. Takahashi, M. Takeda, M. Kurono, and Y. Suzuki. Pharmacological studies of azosemide (SK-110), a diuretic (1). Diuretic action in normal animals.Oyo Yakuri 28:819–835 (1984).

    CAS  Google Scholar 

  31. M. Hayashi, K. Nakuno, K. Mori, K. Niu, K. Mizuno, A. Yamamoto, M. Kouketsu, M. Kurono, and Y. Suzuki. Pharmacological studies of azosemide (SK-100), a diuretic (2). Diuretic action in rats with experimental model disease.Oyo Yakuri 28:837–849 (1984).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, Seoul National University, San 56-1, Shinlim-Dong, Kwanak-Gu, 151-742, Seoul, Korea

    Sun H. Lee & Myung G. Lee

Authors
  1. Sun H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Myung G. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper was supported in part by Non-Directed Research Fund, Korea Research Foundation, 01-F-0124, 1994. This paper is taken from a dissertation submitted by Sun H. Lee to the Graduate School, Seoul National University, in partial fulfillment of Doctor of Philosophy Degree requirements.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S.H., Lee, M.G. Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: Absorption from various GI segments. Journal of Pharmacokinetics and Biopharmaceutics 24, 551–568 (1996). https://doi.org/10.1007/BF02353480

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02353480

Key Words

Search

Navigation